vTv Therapeutics (VTVT) Accumulated Expenses (2014 - 2015)
vTv Therapeutics' (VTVT) quarterly Accumulated Expenses came in at $1.0 million in Q4 2015, up 11455.56% year-over-year from N/an in Q4 2014, and up 11455.56% quarter-over-quarter from $9000.0 in Q4 2014.
Analysis
vTv Therapeutics (VTVT) Accumulated Expenses (2014 - 2015) Analysis & Trends
vTv Therapeutics has disclosed Accumulated Expenses across 2 years of filings, most recently posting $1.0 million for Q4 2015.
- In Q4 2015, Accumulated Expenses rose 11455.56% year-over-year to $1.0 million; the TTM figure through Dec 2015 stood at $1.0 million (up 11455.56% YoY), while the FY2015 annual figure was $1.0 million, up 11455.56% from the prior year.
- Accumulated Expenses came in at $1.0 million for Q4 2015 at vTv Therapeutics, up from $9000.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $1.0 million in Q4 2015 to a low of $9000.0 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - |